OTC •
Healthcare •
Biotechnology •
Quote as of 05/05/2026 12:51
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeOTC
Market Capitalization0.0418 mln
Float30.14 mln
Earnings Date05/13/2026
EPS
0.19
Marginal
P / E
0.00
Anomalous
Piotroski F-Score
3
/ 9
Below average
Beneish M-Score
21.52
Highly suspicious
Relative Strength
100
/ 100
Top performer
Debt / Equity
-0.88
Negative equity
Business Description
Carisma Therapeutics Inc. is a Philadelphia-based biotechnology company founded in 2016 that develops new treatments for liver disease and cancer. Its pipeline includes therapies targeting liver fibrosis and hard-to-treat solid tumors such as pancreatic, ovarian, and lung cancers, with one program already in Phase I clinical trials. The company works with ModernaTX Inc. on gene therapy approaches in oncology and is advancing a novel cell therapy platform designed to attack tumors from within the body.
